| Interacting proteins: P16284 and P05106 |
Pubmed |
SVM Score :0.0 |
| The predicted primary structure of the GPA 2 encoded protein ( GP 2 alpha ) is homologous to mammalian G proteins [ inhibitory and stimulatory G proteins ( Gi and Gs , respectively ) , a G protein of unknown function ( Go ) , and transducins ( Gt ) ] as well as yeast GP 1 alpha . ^^^ |
|
| Interacting proteins: P16284 and P05106 |
Pubmed |
SVM Score :0.0 |
| Receptor expression was measured by flow cytometry with monoclonal murine anti human antibodies CD 9 ( p 24 ) , CD42B ( Ib ) , CD41b ( IIb ) , CD 61 ( IIIa ) , CD41a ( IIb / IIIa ) , CD49b ( VLA 2 ) , CD62p ( P selectin ) , CD 31 ( PECAM 1 ) , and CD51 / CD61 ( vitronectin ) . ^^^ |
|
| Interacting proteins: P16284 and P05106 |
Pubmed |
SVM Score :0.0 |
| The most intense and consistent degree of reactivity was seen using MAB to CD 9 , CD 13 , CD 29 , CD 31 , CD 44 , CD 46 , CD 51 , CD 54 and CD 55 , although reactivity was also observed using MAB belonging to CD 41 , CD 47 , CD 49 , CD 61 and CD 71 , in addition to a number of non clustered MAB . . ^^^ |
|
| Interacting proteins: P16284 and P05106 |
Pubmed |
SVM Score :0.0 |
| Tissue sections were stained by standard histochemical and immunocytochemical methods , the latter using antibodies to platelet membrane glycoprotein IIIa ( CD 61 ) , and vascular endothelium ( CD 31 ) . ^^^ |
|
| Interacting proteins: P16284 and P05106 |
Pubmed |
SVM Score :0.0 |
| Circulating platelets ( analyzed by Facscan ) showed some increase in the expression of CD11a and CD 62 , but little change in CD 31 and CD 61 . ^^^ |
|
| Interacting proteins: P16284 and P05106 |
Pubmed |
SVM Score :0.0 |
| In conclusion , CML samples at diagnosis showed increased fibrosis and decreased CD 31 and CD 61 expression compared to controls . ^^^ |
|
| Interacting proteins: P16284 and P05106 |
Pubmed |
SVM Score :0.0 |
| TNF alpha or IL 1beta did not change the expression of CD 9 , CD 13 , CD 16 , CD 23 , CD 29 , CD 31 , CD 32 , CD 35 , CD 45 , CD 61 , or CD 64 in BEAS 2B cells . ^^^ |
|
| Interacting proteins: P16284 and P05106 |
Pubmed |
SVM Score :0.0 |
| Receptor expression was measured by flow cytometry with monoclonal antibodies to p 24 ( CD 9 ) , Ib ( CD42b ) , IIb ( CD41b ) , IIIa ( CD 61 ) , IIb / IIIa ( CD41b / CD61 ) , very late antigen 2 ( CD49b ) , P selectin ( CD62p ) , platelet / endothelial cell adhesion molecule 1 ( CD 31 ) ; and vitronectin ( CD51 / CD61 ) . ^^^ |
|
| Interacting proteins: P16284 and P05106 |
Pubmed |
SVM Score :0.0 |
| Flow cytometry of migrated CD4+ T cells demonstrated that activated , but not resting , T cells acquired a variety of endothelial surface determinants , including CD 31 , CD49d , CD 54 , CD 61 , and CD62E . ^^^ |
|
| Interacting proteins: P16284 and P05106 |
Pubmed |
SVM Score :0.0 |
| Monoclonal antibodies ( mAbs ) of different immunoglobulin G subclass directed against mouse GPIIbIIIa , GPIIIa , GPIbalpha , GPIb 9 , GPV , and CD 31 were generated and characterized biochemically . ^^^ MAbs against GPIb 9 , GPV , CD 31 , and linear epitopes on GPIIIa had mild and transient effects on platelet counts and induced no spontaneous bleeding . ^^^ |
|
| Interacting proteins: P16284 and P05106 |
Pubmed |
SVM Score :0.0 |
| These markers include surface proteases ( CD 10 , CD 13 and CD 26 ) , antigen presenting cell markers ( CD 13 , CD 14 , CD 35 and CD 63 ) , integrins ( CD 18 and CD 61 ) , epithelial / endothelial markers ( CD 21 , CD 31 , CD 47 and CD 59 ) and finally , CD 25 and CD 28 . ^^^ |
|
| Interacting proteins: P16284 and P05106 |
Pubmed |
SVM Score :0.0 |
| The megakaryocytes were reactive for CD 31 , CD 61 , and von Willebrand factor , but not for cytokeratin ( AE1 / AE3 ) . ^^^ |
|
| Interacting proteins: P16284 and P05106 |
Pubmed |
SVM Score :0.0 |
| MOLM 16 revealed characteristics of the megakaryocytic lineage in terms of immunophenotyping being positive for CD 9 , CD 31 , CD 36 , CD 41 , CD 61 , CD62P , CD 63 , CD 110 , CD 151 , thrombospondin , von Willebrand factor ( vWf ) , and fibrinogen . ^^^ |
|
| Interacting proteins: P16284 and P05106 |
Pubmed |
SVM Score :0.0 |
| Detection of atypical megakaryocytes in bone marrow biopsies , especially in cases of myelodysplastic syndromes ( MDS ) , chronic myeloproliferative disorders ( CMPD ) and acute leukemias , is facilitated by staining for markers such as Ulex europaeus agglutinin ( UEA ) J , CD 31 , CD 61 and von Willebrand factor ( VWF ) , the latter being considered the most sensitive . ^^^ |
|
| Interacting proteins: P16284 and P05106 |
Pubmed |
SVM Score :0.0 |
| Immunohistochemistry can help diagnose and distinguish four variants : granulocytic myeloperoxidase ( MPO+ , CD 68+ [ KP1+ / , PGM 1 ] lysozyme+ , CD 34+ / ) , monoblastic ( MPO , CD 68+ , [ KP1+ , PGM1+ ] lysozyme+ , CD 34 ) , myelomonoblastic ( MPO , CD 68+ , [ KP1+ , PGM1+ ] lysozyme+ , CD 34 ) , or megakaryoblastic ( positivity for factor 8 , CD 61 , CD 31 ) . ^^^ |
|
| Interacting proteins: P16284 and P05106 |
Pubmed |
SVM Score :0.0 |
| OBJECTIVE : To investigate the role of expression of platelet membrane glycoprotein CD 31 , CD 61 and CD62p in the pathogenesis of decompression sickness . ^^^ At 60th minute after reducing to normal pressure , the expression of CD 31 , CD 61 and CD62p on platelet membrane in mice was measured by flow cytometry . ^^^ RESULTS : The mean fluorescence intensity of CD 31 , CD 61 and positive percentage of CD62p on platelet membrane [ ( 18 . 64 + / 1 . 01 ) , ( 271 . 06 + / 24 . 25 ) , ( 4 . 48 % + / 0 . 43 % ) respectively ] in decompression sickness group were significantly increased compared with normal control group [ ( 16 . 89 + / 1 . 69 ) , ( 234 . 09 + / 15 . 96 ) , ( 3 . 00 % + / 0 . 66 % ) respectively ] ( P < 0 . 05 , P < 0 . 01 ) . ^^^ CONCLUSION : Inadequately rapid decompression may induce up regulation of platelet membrane glycoprotein CD 31 , CD 61 and CD62p expression in mice , which may lead to thrombosis . . ^^^ |
|
| Interacting proteins: P16284 and P05106 |
Pubmed |
SVM Score :0.0 |
| Thirty three cases of KH were reviewed and immunostained for alpha smooth muscle actin , various endothelial markers ( CD 31 , CD 34 , vWf , FLI 1 ) , a platelet marker ( CD 61 ) , and the juvenile hemangioma associated markers GLUT 1 and Lewis Y antigen ( LeY ) . ^^^ |
|
| Interacting proteins: P16284 and P05106 |
Pubmed |
SVM Score :0.0 |
| Flow cytometric analysis showed that fetal lung MSCs expressed CD 13 , CD 29 , CD 44 , CD 90 , CD 105 , CD 166 , and HLA ABC , but not CD 14 , CD 31 , CD 34 , CD 38 , CD41a , CD42b , CD 45 , CD49d , CD 61 , CD 106 , CD 133 , and HLA DR . ^^^ |
|
| Interacting proteins: P16284 and P05106 |
Pubmed |
SVM Score :0.0 |
| Cells were immunophenotyped by four color fluorescence using antibodies against CD11c , CD 31 , CD49e , CD 61 , CD62L , CD 117 , and HLA DR . ^^^ |
|
| Interacting proteins: P16284 and P05106 |
Pubmed |
SVM Score :0.0 |
| This study was undertaken to examine the tissue distribution of a broad spectrum of monoclonal antibodies ( mAbs ) containing tetraspan antigens ( CD 9 , CD 63 , CD 151 ) , endothelial cell antigens ( CD 31 , CD 36 , CD 105 , CD 106 , CD 146 ) , integrins ( CD49a f , CD 29 , CD 41 , CD 51 , CD 61 ) , CD 39 , CD 98 , CD 99 , CD 143 and , CD 147 supplied from fifth and sixth international workshops and conferences on human leukocyte differentiation antigens in a comparative manner in human OA and normal synovium . ^^^ |
|
| Interacting proteins: P16284 and P05106 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16284 and P05106 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16284 and P05106 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16284 and P05106 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16284 and P05106 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16284 and P05106 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16284 and P05106 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16284 and P05106 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16284 and P05106 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16284 and P05106 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16284 and P05106 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16284 and P05106 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16284 and P05106 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16284 and P05106 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16284 and P05106 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16284 and P05106 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16284 and P05106 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16284 and P05106 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16284 and P05106 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16284 and P05106 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16284 and P05106 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16284 and P05106 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16284 and P05106 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16284 and P05106 |
Pubmed |
SVM Score :0.0 |
| NA |
|